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Culture of human pancreatic islets is now routinely carried out prior to clinical islet allotransplantation, using 
conditions that have been developed empirically. One of the major causes of early islet destruction after trans-
plantation is the process termed instant blood-mediated inflammatory reaction (IBMIR). The aim of this study 
was to develop in vitro methods to investigate IBMIR and apply them to the culture conditions used routinely 
in our human islet isolation laboratory. Freshly isolated or precultured (24 h, 48 h) human islets were incubated 
in either ABO-compatible allogeneic human blood or Hank’s buffered salt solution (HBSS) for 1 h at 37°C. 
Tissue factor (TF) expression and leukocyte migration were assessed by light microscopy. TF was also quanti-
fied by ELISA. To assess b-cell function, glucose-stimulated insulin secretion (GSIS) assay was carried out. 
The extent of islet b-cell damage was quantified using a proinsulin assay. Islets cultured for 24 h had higher 
GSIS when compared to freshly isolated or 48-h precultured islets. Freshly isolated islets had significantly 
higher TF content than 24-h and 48-h precultured islets. Incubation of freshly isolated human islets in alloge-
neic human blood released 6.5-fold higher level of proinsulin in comparison to freshly isolated human islets 
in HBSS. The high level of proinsulin released was significantly attenuated when precultured islets (24 h or 
48 h) were exposed to fresh blood. Histological examination of fresh islets in blood clot showed that some islets 
were fragmented, showing signs of extraislet insulin leakage and extensive neutrophil infiltration and necrosis. 
These features were markedly reduced when the islets were cultured for 24 h. These results suggest that our 
standard 24-h islet culture is markedly beneficial in attenuating IBMIR, as evidenced by increased GSIS, lower 
content of TF, decrease islet fragmentation, and proinsulin release.
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INTRODUCTION
Allogeneic islet cell transplantation is now a success-
ful therapy for certain selected patients diagnosed as hav-
ing type 1 diabetes mellitus. However, the success of the 
procedure is limited by the profound islet attrition that 
occurs in the immediate posttransplant period (17). This 
limits the functional capacity to regulate glucose levels 
even when four donors are used, corresponding to around 
20–30% of that in a healthy nondiabetic subject (16).
One of the major causes of islet attrition at the early 
stages of transplantation has been termed instant blood-
mediated inflammatory reaction (IBMIR). It occurs rap-
idly when isolated islets are exposed to human blood 
following infusion in the portal vein. It is thought to be 
an innate inflammatory response, triggering activation of 
complement and infiltration of polymorphonuclear cells 
into “foreign” material. Investigation of IBMIR is made 
difficult by the lack of a murine allograft model, at least 
not a model of similar severity to that found in human 
islet allografts. Investigation has implicated activated tis-
sue factor (TF) leading to the generation of thrombin, a 
potent inflammatory mediator, resulting in activation of 
platelets and neutrophils. This could activate the coagula-
tion cascade in an islet recipient (2,12). Thrombin inhibi-
tion abrogates the IBMIR response to human islets (14).
Culture of human islets prior to transplantation is 
beneficial to clinical islet allotransplantation in terms 
of its logistical advantages (7). It provides a window of 
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opportunity to complete quality assurance tests, to mobi-
lize the patients, or to transport the islets to another center 
for transplantation. Islet culture may lessen islet immu-
nogenicity by depleting viable hematogenous and lym-
phoid cells (9). However, since there is some reduction of 
islet equivalent number with culture, there is an ongoing 
debate as to whether cultured islets are superior to freshly 
isolated islets in transplantation (5,10).
We have previously confirmed that exposure of freshly 
isolated human islets to allogeneic blood results in sig-
nificant destruction of islet tissue with activation of the 
coagulation cascade and consumption of neutrophils and 
monocytes (18). We hypothesized that culture of islets 
improved the subsequent islet graft function. Hence, the 
aim of the present study was to assess the IBMIR effect 
produced by freshly isolated islets compared to islets cul-
tured for 1 or 2 days.
MATERIALS AND METHODS
Following appropriate consent and ethical approval 
from local and national committees, human pancreata 
(n = 5) were retrieved from heart-beating donors (age 
range 35–61 years; gender three females, two males; BMI 
range 21–36; cold ischemia times <10 h).
Human Islet Isolation
Isolation was performed according to a modified 
Edmonton protocol (17). In brief, the pancreatic duct 
was securely cannulated, and cold collagenase type NB1 
and neutral protease (Serva Electrophoresis, Heidelberg, 
Germany) were injected slowly, ensuring no leaks. 
Digestion of the pancreas at 37°C was allowed to proceed 
in the digestion chamber (Biorep Technologie, Miami, FL, 
USA), and the circuit fluid was sampled until free-cleaved 
islet tissue was seen [using 0.25% dithizone (Sigma-
Aldrich, Dorset, UK) to identify the islets]. Once cleaved 
islets were seen, the digest was then collected in conical 
flasks (Corning plastics; Fisher Scientific, Leicestershire, 
UK) containing 8–10 ml of 20% human albumin (Blood 
Products Laboratory, Elstree, UK). Islets were purified 
using a continuous Biocoll density gradient (Autogen 
Bioclear, Wiltshire, UK) on a COBE 2991 cell separator 
(Cobe Instruments, Lakewood, CO, USA). The volume 
and purity of islets in the final sample was assessed by 
microscopic sizing on a grid after staining with dithizone. 
Viability and functionality were assessed by fluorescein 
diacetate/ethidium bromide stain (Sigma-Aldrich) (4) and 
glucose-stimulated insulin secretion (GSIS), respectively. 
All preparations used demonstrated islet viability around 
80–95% immediately after isolation.
Islet Culture
Islet preparations were maintained in standard flat- 
bottomed 175-ml gas-permeable flasks (Sarstedt, Leicester, 
UK), each containing 30 ml of our standard culture 
medium [CMRL (PAA, Somerset, UK): 5.5 mM glucose 
(Sigma-Aldrich), with added 1% l-glutamine (PAA), 
1% penicillin/streptomycin (PAA), 50 ml of 20% human 
albumin, and 1% HEPES (Lonza, Basel, Switzerland)] 
incubated at 37°C, 5% CO2 in air for 24 and 48 h. Islets 
aliquoted at 30,000 IEQ per flask. These volumes were 
enough to completely cover the tissue at the gas–fluid 
interface yet minimize hypoxia.
Blood Samples
Following informed consent, blood was collected from 
healthy volunteers (n = 3; age range 25–60 years; gender 
one female, two males). All the blood samples used in the 
experiments were blood group matched with islets and 
collected from healthy individuals who had not undergone 
previous blood transfusion, pregnancy, or transplantation 
and whose panel reactive antibody screen was negative. 
Fresh blood was used instantly, whereas citrated blood 
was used between 30 and 60 min after collection.
Histology
The clots containing the islets were fixed in 4% para-
formaldehyde (Sigma-Aldrich), dehydrated, and embed-
ded in paraffin wax, serial sectioned (5 µm) to extinction, 
and stained with hematoxylin and eosin (H&E; Sigma-
Aldrich). For cryosectioning, clots containing the 
islets were accumulated in a conical receiver (Corning, 
Scientific Laboratory Supplies Limited, Nottingham, 
UK), flash frozen, and cryostat (Bright Instrument 
Company Limited, Cambridgeshire, UK) mounted, then 
serial sectioned (5 µm) to extinction.
Immunohistochemistry
The sections were incubated with murine monoclonal 
anti-human TF (CD142) (No. 4509; 1:1,000; American 
Diagnostica, Greenwich, CT, USA), an in-house guinea 
pig anti-human insulin antibody (1:5,000), murine anti-
human insulin antibody (1:1,000; Sigma-Aldrich), murine 
monoclonal anti-human neutrophil elastase NP57 (1:1,000; 
DakoCytomation, Denmark) with appropriate controls. 
The peroxidase or alkaline phosphatase-conjugated goat 
anti-mouse (Sigma-Aldrich) and rabbit anti-guinea pig 
(DAKO, Cambridgeshire, UK) secondary antibodies were 
diluted at 1:50. Positive binding was revealed by addition 
of diaminobenzidine substrate chromogen (Sigma-Aldrich) 
and counterstained with hematoxylin. The distribution 
of neutrophils in the clots and adjacent to the islets was 
assessed by semiautomatic morphometry (Axiovision, 
Zeiss, Germany), the degree of leukocyte infiltration 
expressed as pixels per neutrophil in three zones (within 
islet, peri-islet, rest of field). Image analysis software was 
used to count the number of neutrophils, and statistical 
confirmation was reached only if islets with no neutrophils 
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were excluded. Log transformation was used to normalize 
the remaining data, and Bonferroni post hoc test for mul-
tiple comparisons was performed.
TF Assay
Fifty handpicked human islets cultured for 0 h, 24 h, 
or 48 h were used to measure TF content. The islets were 
lysed at each time point by repeated freeze–thaw in buf-
fer [50 mM Tris-HCl (Sigma-Aldrich), 100 mM NaCl 
(Baxter, Northampton, UK), 0.1% Triton X-100 (Sigma-
Aldrich), pH 7.4] and allowed to incubate for 30 min at 
37°C. Samples were immediately assayed without dilu-
tion (Actichrome Tissue Factor; American Diagnostica).
GSIS
Ten handpicked human islets from each preparation 
(fresh or cultured for 24 h, 48 h) were incubated for 45 
min at 37°C in 2 ml RPMI-1640 (Gibco, Invitrogen, UK) 
media containing 3 mmol/L d-glucose, 1% human albu-
min, 1% l-glutamine, and 0.3% penicillin/streptomycin 
followed by stimulation with 16 mmol/L d-glucose for 
45 min. Human insulin was measured in aliquots of the 
media using a Mercodia human insulin enzyme-linked 
immunosorbent assay (ELISA) (Uppsala, Sweden).
Proinsulin Assay
Fifteen size-matched handpicked human islets 
(freshly isolated or following culture for 0 h, 24 h, 48 h) 
were incubated for 1 h at 37°C in 360 µl Hank’s bal-
anced salt solution (HBSS; Lonza) (control), 360 µl fresh 
human allogeneic blood, or 360 µl citrated-recalcified 
allogenic blood. Allocation of islets was protected from 
observer bias by final step random selection of islets for 
each condition. Human blood without islets was used as 
a negative control. After incubation for 1 h, blood serum 
was collected from the islets. The proinsulin released 
in the blood/serum suggests b-cell destruction as pre-
viously described (1,18). To ascertain that, prior to the 
experiments, the islets were not disrupted thus leaking 
proinsulin, we determine the proinsulin content after 
the experiment. The islets in the clots were lysed by 
repeated freeze–thaw to allow extraction of proinsulin 
content. The samples were then centrifuged at 211 × g 
for 5 min, and the supernatants were stored at −20°C. 
Human proinsulin was assayed by Mercodia Proinsulin 
ELISA. This assay cross-reacts with proinsulin Des and 
proinsulin Split but does not cross-react with human 
insulin.
Statistical Analysis
The significance of changes in level of TF or proinsulin 
was tested by analysis of variance (ANOVA). If ANOVA 
indicated a significant difference, the data were analyzed 
by using Bonferroni method for multiple comparisons as 
a post hoc test for the difference between groups. A value 
of p £ 0.05 was considered statistically significant. The 
statistical analysis of infiltrating leukocytes was altered, 
and this is discussed in the relevant section.
RESULTS
Effect of Culture on Human Pancreatic 
Islet Functionality
The functionality of human islets was assessed by 
GSIS (Fig. 1). Freshly isolated islets stimulated with 3 mM 
glucose released 5.3 ± 1.5 mU/L/islet insulin, and when 
stimulated with 16 mM glucose released 6.7 ± 1.4 mU/L/
islet insulin. Islets cultured for 24 h secreted 5.2 ± 1.0 mU/L/
Figure 1. Effect of culture on human islet functionality. The functionality of human pancreatic islets was assessed by GSIS. Islets 
cultured for 24 h secreted significantly higher insulin when compared to freshly isolated islets (*p £ 0.05; n = 5 independent experi-
ments were carried out).
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islet insulin when stimulated with 3 mM glucose when 
compared to 9.7 ± 1.2 mU/L/islet insulin when stimulated 
with 16 mM glucose. Islets cultured for 48 h secreted 
4.0 ± 0.5 mU/L/islet insulin when stimulated with 3 mM 
glucose when compared to 5.7 ± 0.9 mU/L/islet insulin 
when stimulated with 16 mM glucose. Human islets cul-
tured for 24 h secreted significantly higher insulin con-
centration in response to 16 mM glucose when compared 
to stimulation with 3 mM glucose and was significantly 
higher compared to freshly isolated islets.
Effect of Culture on Human Islet TF Production
Human islets in normal pancreas were strongly posi-
tive for TF (Fig. 2Ai), when compared to the exocrine 
tissue, which was virtually negative. Insulin-expressing 
isolated islets in blood clot were also strongly positive 
Figure 2. Effect of culture on human islet TF production. (A) (i) Human pancreatic tissue shows islet cells immunolabeled for TF 
(arrow). (ii) Negative control showing expression of IgG. (iii) Islet expressing TF. (iv) Insulin-producing islet in blood clot expressed 
both TF and insulin. Scale bar: 100 µm. (B) TF content was measured in freshly isolated or precultured (24 h, 48 h) islets. The con-
centration of TF per islet decreased significantly after 24 h and 48 h in culture (*p ≤ 0.05). At 48 h in culture, the TF concentration per 
islet was significantly lower when compared to 24 h in culture (+p ≤ 0.05).
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for TF (Fig. 2Aiii, iv). Freshly isolated human pancre-
atic islets had significantly higher TF content than 24-h 
and 48-h precultured islets. Islets cultured for 48-h had 
significantly lower TF content when compared to freshly 
isolated and 24-h cultured islets (Fig. 2B).
Effect of Culture on Human Islet Proinsulin Release
Freshly isolated islets incubated in HBSS for 1 h 
released more proinsulin than 24-h and 48-h precultured 
islets, which were both below the lowest detectable limit 
(shown as DL in Fig. 3). Incubation of freshly isolated 
or precultured (24 h, 48 h) human islets in fresh ABO-
compatible allogeneic blood for 1 h significantly aug-
mented the release of proinsulin when compared to their 
corresponding controls (freshly isolated or precultured 
islets in HBSS). Freshly isolated islets in blood released 
significantly higher proinsulin when compared to precul-
tured islets (24 h or 48 h) incubated in fresh blood. A simi-
lar trend was observed when fresh blood was substituted 
with citrated-recalcified blood. To determine the proinsu-
lin release is not due to leakage of proinsulin as a result 
of islet disruption prior to the experiment, we determine 
the islet proinsulin content. At the end of the experiment, 
freshly isolated islets in citrated-recalcified blood were 
disrupted, and the proinsulin content (129.5 ± 27.7 pmol/
L/15 islets) was not significantly different from that found 
in islets cultured for 24 h exposed to the citrated-recalcified 
blood (127.6 ± 18.4 pmol/L/15 islets). Blood on its own 
had minimal proinsulin well below the DL.
Histological Assessment of Human Islets (Fresh and 
Precultured) After Incubation in Allogenic Blood
Histological examination of fresh islets incubated in 
fresh blood for 1 h showed that the islet structure was 
generally retained, but some of the islets were frag-
mented, showing pycnotic nuclei (Fig. 4A) and signs of 
extraislet insulin leakage (Fig. 4B). These features were 
markedly reduced when the islets were cultured for 24 h 
(Fig. 4D, E) before exposure to fresh blood.
Islets cultured for 48 h before exposure to fresh blood 
showed b-cell necrosis with insulin leakage, individual islet 
degranulation of b-cells, and vacuolation (Fig. 4G, 1H).
Neutrophils were easily identified in the blood clot and 
appeared to migrate to the vicinity of the islet within 1 h. 
To discover whether there was specific attraction of neu-
trophils to the islet, the number of neutrophils infiltrating 
Figure 3. Effect of culture on human islet proinsulin release. (A) Islets in HBSS: Proinsulin concentration above lowest detectable 
limit (DL) was found in freshly isolated islets in HBSS but was below the limit following culture (24 h, 48 h). (B) Islets in fresh blood: 
Proinsulin concentration, when freshly isolated islets were exposed to fresh blood, was 6.5-fold more than that found in control. These 
values were significantly decreased when islets were precultured for 24 h, 48 h. (C) Islets in citrated-recalcified blood: Similar high 
levels of proinsulin were found when islets were placed in citrated-recalcified blood. These values were significantly decreased when 
islets were precultured for 24 h, 48 h. Normal blood contains no detectable proinsulin. n = 4 independent experiments were carried out. 
Results shown are the means + SEM. *p £ 0.05 when compared to corresponding controls (islet + HBSS). +p £ 0.05 when compared to 
fresh blood or citrated blood. $p £ 0.05 when compared to islet with fresh blood or citrated blood at 0 h.
2510 RAMNATH ET AL.
the peri-islet areas was compared to the neutrophils found 
in the nonislet areas. When freshly isolated islets were 
incubated with fresh allogeneic blood for 1 h (Fig. 4C), 
there was a significant (p < 0.05) accumulation of neutro-
phils into the islets, when compared to precultured islets 
(24 h, 48 h) mixed with fresh blood (Fig. 4F, I). However, 
the remaining data were too sparse to achieve statistical 
significance for any other comparison of conditions.
DISCUSSION
Several studies have demonstrated that IBMIR occurs 
in vitro or in vivo during islet infusion into the hepatic 
portal vein (1,2,18). IBMIR has been shown to cause dis-
ruption of islet morphology (2,12), and it is likely to cause 
loss or primary nonfunctional transplanted islets (19). 
Previously, we have demonstrated that within 1 h of incu-
bation in allogeneic blood, 37% of islets showed features 
of severe damage on histologic evaluation, confirmed by 
an increase in proinsulin release compared with control 
islets. Cell death was predominantly through necrosis 
with mononuclear and neutrophil infiltration (18).
To determine whether culture of islets improved sub-
sequent islet graft function by attenuating IBMIR, we first 
assessed changes in functionality of human islets cultured 
for 0 h, 24 h, 48 h by GSIS. At the onset of the experi-
ment, all the islets were viable, assessed by fluorescein 
diacetate/ethidium bromide staining. We demonstrated 
that cultured islets especially after 24 h were more func-
tional when compared to freshly isolated islets or to 48-h 
precultured islets. These results were substantiated by the 
insulin staining in Figure 4B, E, and F. Freshly isolated 
islets (Fig. 4B) leaked insulin, potentially due to islet dis-
ruption. Precultured islet (24 h) expressed insulin within 
the cells, suggesting the islet was intact. Precultured islets 
Figure 4. Histological assessment of human islets (fresh and precultured) after incubation in allogenic blood. Morphology of human 
islets (Is) in blood clots. Adjacent columns show representative serial sections. (A, B, C) Freshly isolated islets. (D, E, F) Islets pre-
cultured for 24 h and (G, H, I) precultured for 48 h. (A, D, G) H&E staining; (B, E, H) immunolabeled for insulin (brown); (C, F, I) 
immunolabeled for neutrophils. Scale bar: 100 µm.
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(48 h) expressed considerably less insulin when compared 
to freshly isolated or 24-h precultured islets, possibly due 
to islet degranulation of b-cells and vacuolation.
We then determined the expression of TF, a media-
tor of IBMIR, on human islets cultured for 0 h, 24 h, 
and 48 h. TF is a transmembrane glycoprotein of the 
cytokine receptor superfamily type 1 and when activated 
is a major cellular trigger of blood coagulation. We have 
shown that human islets in vivo (pancreatic section) and 
in vitro express the proinflammatory mediator TF, as 
previously reported (8). Anti-TF and TF-inhibitory drug 
site-inactivated factor VIIa have been shown to inhibit 
IBMIR in vitro (18). A recent report has described the 
use of antisense TF RNA to switch off TF production in a 
porcine model of neonatal islets, thus suppressing IBMIR 
(11). These findings suggested that IBMIR is triggered 
by TF. Moreover, it has also been demonstrated that TF 
released by human islets affects islet engraftment in type 
1 diabetic patients (3). It has been shown that TF expres-
sion is significantly lowered by culturing the islets in the 
antioxidant nicotinamide (13). However, we found that 
even without nicotinamide, 24-h and 48-h precultured 
islets produce significantly less TF compared to freshly 
isolated islets. Cultured islets have been shown to express 
lower MAP kinase activation and heat shock protein 
when compared to freshly isolated islets (6). A decrease 
in signaling molecule MAP kinases and heat shock pro-
tein could suggest a reduction in inflammation, including 
a decrease in TF and therefore increased viability.
We also investigated ATP content of cultured islets as 
another parameter of islet viability (data not shown). The 
ATP content was used in the previous report of culture (6), 
and indeed, we found it was marginally higher in cultured 
islets than that of freshly isolated islets, suggesting recov-
ery from stress and maintenance of cellular homeostasis and 
function. However, the overlap of data from the two groups 
was too great to make it a useful addition to the tests.
To determine the effects of cultured islets on IBMIR, 
proinsulin assay was carried out to measure the ongoing 
islet disintegration. Incubation of freshly isolated islets in 
allogeneic blood for 1 h released significantly more pro-
insulin compared to islets in HBSS. The proinsulin con-
centration was considerably reduced in precultured islets 
incubated in blood, suggesting that culture attenuates 
blood-induced islet destruction. Islets cultured for 24 h 
released less proinsulin, but had high proinsulin content, 
confirming that these islets were largely unaffected by the 
blood. IBMIR is also known to trigger activation of poly-
morphonuclear cells in blood (18). In our study, we have 
showed that 24-h culture was also beneficial in attenuat-
ing neutrophil infiltration when compared to freshly iso-
lated islets. Mice were not used as a bioassay in this study, 
mainly because the mouse model is flawed by the incom-
patibility of mouse receptors for human insulin (15).
In the present study, we have shown that the standard 
operating protocol for 24-h human islet culture used in 
our islet transplantation program is clearly beneficial 
in attenuating IBMIR. It decreases islet fragmentation, 
as evidenced by a reduction in proinsulin release and 
the histological assessment of the islet morphology. 
Moreover, 24-h human islet culture secreted more insu-
lin, high GSIS, and had lower content of the proinflam-
matory mediator TF when compared to freshly isolated 
islets. Islets precultured for 48 h had reduced functional-
ity, lower GSIS, and very low insulin expression despite 
lowered TF expression and proinsulin levels. These find-
ings would suggest that 24-h culture may be beneficial 
but not 48 h. The increase formation of vacuoles within 
the 48-h preculture could potentially be responsible for 
the low GSIS and low insulin expression observed. More 
work needs to be done to fully understand the beneficial 
effect of 24-h culture on IBMIR.
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